Effects of a beta blocker and spironolactone on plasma homocysteine levels [6]

International Journal of Cardiology

Volumn 91, Issue 2-3, 2003, Pages 259-260

  Korkmaz, Mehmet E ^a   Atar, Ilyas ^a   Tayfun, Egemen ^a   Yildirir, Aylin ^a   Ulucam, Melek ^a   Ozin, Bülent ^a   Muderrisoglu, Haldun ^a   Turan, Munire ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HOMOCYSTEINE; METOPROLOL; METOPROLOL TARTRATE; SPIRONOLACTONE;

ADULT; AGED; BLOOD LEVEL; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPIRONOLACTONE; TIME FACTORS;

EID: 1642291759     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(03)00034-2     Document Type: Letter

References (10)

1. Stampfer M.J., Malinow M.R., Willett W.C., et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA. 286:1992;877-881.
2. Arnesen E., Refsum H., Bonaa K.H., et al. Serum total homocysteine and coronary artery disease. Int J Epidimiol. 24:1995;704-709.
3. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 337:1997;230-236.
4. Kanani P.M., Sinkey C.A., Browning R.L., et al. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation. 100:1999;1161-1168.
5. Charpiot P., Bescond A., Augier T., et al. Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazide. Matrix Biol. 17:1998;559-574.
6. Sutton-Tyrrell K., Bostom A., Selhub J., Zeigler-Johnson C. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation. 96:1997;1745-1749.
7. Lip G.Y.H., Edmunds E., Martin S.C., Jones A.F., Blann A.D., Beevers D.G. A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage. Am J Hypertens. 14:2001;627-631.
8. Sharabi Y., Doolman R., Rosenthal T., et al. Homocysteine levels in hypertensive patients with a history of cardiac or cerebral atherothrombotic events. Am J Hypertens. 12:1999;766-771.
9. Do K.Q., Benz B., Sorg O., Pellerin L., Magistretti P.J. Beta-Adrenergic stimulation promotes homocysteic acid release from astrocyte cultures: evidence for a role of astrocytes in the modulation of synaptic transmission. J Neurochem. 68:(6):1997;2386-2394.
10. Morrow L.E., Grimsley E.W. Long-term diuretic therapy in hypertensive patients: Effects on serum homocysteine, vitamin B6, vitamin B12, and red blood cell folate concentrations. South Med J. 92:(9):1999;866-870.